Publications by authors named "Lisa Pleyer"

44Publications

IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?

Br J Haematol 2020 Aug 17;190(3):314-317. Epub 2020 May 17.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496607PMC
August 2020

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?

Cancers (Basel) 2019 Feb 21;11(2). Epub 2019 Feb 21.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg 5020, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11020252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406956PMC
February 2019

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.

Eur J Haematol 2019 May 28;102(5):437-441. Epub 2019 Feb 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849823PMC
May 2019

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.

Cancer Med 2018 12 10;7(12):5962-5972. Epub 2018 Nov 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308077PMC
December 2018

Remission maintenance treatment options in chronic lymphocytic leukemia.

Cancer Treat Rev 2018 Nov 10;70:56-66. Epub 2018 Aug 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria; Salzburg Cancer Research Institute and Cancer Cluster Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.003DOI Listing
November 2018

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

Oncotarget 2018 Apr 17;9(29):20928-20940. Epub 2018 Apr 17.

IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945535PMC
April 2018

Time to repeal and replace response criteria for acute myeloid leukemia?

Blood Rev 2018 09 27;32(5):416-425. Epub 2018 Mar 27.

The Alfred Hospital and Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.03.006DOI Listing
September 2018

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Eur J Cancer 2018 04 20;93:69-78. Epub 2018 Mar 20.

IIIrd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183007
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.01.064DOI Listing
April 2018

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.

Wien Klin Wochenschr 2018 Feb 30;130(3-4):115-125. Epub 2018 Jan 30.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory of Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1315-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816094PMC
February 2018

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).

BMC Cancer 2018 01 3;18(1):11. Epub 2018 Jan 3.

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3955-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753540PMC
January 2018

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Oncoimmunology 2017 21;7(1):e1371399. Epub 2017 Sep 21.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1371399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739567PMC
September 2017

Azacitidine in adult patients with acute myeloid leukemia.

Crit Rev Oncol Hematol 2017 Aug 3;116:159-177. Epub 2017 Jun 3.

Hôpital Saint Louis, Institut Universitaire d'Hématologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.05.010DOI Listing
August 2017

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.

Cell Commun Signal 2017 03 31;15(1):13. Epub 2017 Mar 31.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, A-5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12964-017-0168-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374693PMC
March 2017

Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.

Cell Commun Signal 2017 Jan 19;15(1). Epub 2017 Jan 19.

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, A-5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12964-016-0155-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244547PMC
January 2017

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Int J Mol Sci 2016 Jun 27;17(7). Epub 2016 Jun 27.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17071009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964385PMC
June 2016

Digging deep into "dirty" drugs - modulation of the methylation machinery.

Drug Metab Rev 2015 May 8;47(2):252-79. Epub 2015 Jan 8.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute , Salzburg , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/03602532.2014.995379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733942PMC
May 2015

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

Wien Klin Wochenschr 2015 Jan 25;127(1-2):12-5. Epub 2014 Nov 25.

Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-014-0627-0DOI Listing
January 2015

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

Ann Hematol 2014 Nov 21;93(11):1825-38. Epub 2014 Jun 21.

3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Müllner Hauptstrasse 48, 5020, Salzburg, Austria,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00277-014-2126
Web Search
http://link.springer.com/10.1007/s00277-014-2126-9
Publisher Site
http://dx.doi.org/10.1007/s00277-014-2126-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176957PMC
November 2014

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

Leuk Lymphoma 2015 Feb 25;56(2):353-60. Epub 2014 Jun 25.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.916798DOI Listing
February 2015

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.

Leuk Res 2014 Apr 18;38(4):475-83. Epub 2014 Jan 18.

3rd Medical Department with Hematology and Medical Oncology, Hemostasiology, Rheumatology and Infectiology, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Hospital Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.01.006DOI Listing
April 2014

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Oncol Lett 2013 Dec 15;6(6):1756-1758. Epub 2013 Oct 15.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncological Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University of Salzburg, Salzburg A-5020, Austria.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/ol.2013.1629
Publisher Site
http://dx.doi.org/10.3892/ol.2013.1629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834563PMC
December 2013

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia.

Wien Klin Wochenschr 2013 Jan 5;125(1-2):50-3. Epub 2013 Jan 5.

Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-012-0319-6DOI Listing
January 2013

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.

Crit Rev Oncol Hematol 2012 Jun 7;82(3):370-7. Epub 2011 Sep 7.

Department of Internal Medicine I, Division of Haematology & Haemostaseology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2011.08.002DOI Listing
June 2012

Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.

J Clin Oncol 2011 Aug 5;29(24):e696-8. Epub 2011 Jul 5.

University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.8283DOI Listing
August 2011

The impact of storage effects in biobanks on biomarker discovery in systems biology studies.

Biomarkers 2010 Dec 5;15(8):677-83. Epub 2010 Oct 5.

Division of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/1354750X.2010.511265DOI Listing
December 2010

Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.

Acta Derm Venereol 2009 Nov;89(6):631-5

Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-0731DOI Listing
November 2009

Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights.

Discov Med 2009 Oct;8(42):157-64

Laboratory for Immunological and Molecular Cancer Research, IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg 5020, Austria.

View Article

Download full-text PDF

Source
October 2009

Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

Nat Rev Clin Oncol 2009 Jul 2;6(7):405-18. Epub 2009 Jun 2.

Laboratory for Immunological and Molecular Cancer Research and IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.72DOI Listing
July 2009

Tumour-immune cell interactions modulated by chemokines.

Expert Opin Biol Ther 2008 Mar;8(3):269-90

Tyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.8.3.269DOI Listing
March 2008

Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C.

Wien Klin Wochenschr 2007 ;119(7-8):254-8

IIIrd Medical Department (Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases), Private Medical Paracelsus University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-007-0774-7DOI Listing
October 2007